Global X Japan’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-45
Closed -$8.86K 281
2024
Q3
$8.86K Sell
45
-14
-24% -$2.91K ﹤0.01% 281
2024
Q2
$12.2K Sell
59
-14
-19% -$3.17K ﹤0.01% 245
2024
Q1
$19.8K Sell
73
-87
-54% -$20.8K ﹤0.01% 180
2023
Q4
$37.8K Buy
+160
New +$31.5K 0.02% 135

Other funds holding CRL

Global X Japan's CRL Position: Q4 2024 in Review

Global X Japan sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 45 shares — an estimated $8.86K sold.

Global X Japan first reported a position in CRL in Q4 2023 and held it in 4 quarters. The position peaked at $37.8K in Q4 2023. 637 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • Global X Japan reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
  • Global X Japan sold 45 Charles River Laboratories shares in Q4 2024, an estimated $8.86K.
  • Global X Japan first reported a position in Charles River Laboratories in Q4 2023 and held it in 4 quarters.
  • Global X Japan's Charles River Laboratories position peaked at $37.8K in Q4 2023.
  • 637 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Global X Japan's 13F filing for Q4 2024, filed 28 Jan 2025.